Horizon Scanning orientations

In Horizon Scanning, we prepare briefings on new medicinal products and the majority of the indication extensions currently under evaluation by the EMA. The purpose of these briefings is to provide an early and comprehensive overview of medicinal products expected to be marketed in Denmark within the next two to three years. This enables our stakeholders to plan their activities, while allowing Amgros to better prepare for upcoming price negotiations and organise tenders. The briefings are concise fact sheets that provide a quick overview of each medicinal product. On this page, you will find the published briefings listed alphabetically by the name of the active substance (in Danish). We do not prepare briefings for all types of indication extensions. This includes, for example, population extensions (where a medicinal product is used for new age groups) and so-called line extensions, such as new strengths, formulations, or routes of administration

Sign up for our newsletter her

Horizon Scanning Katalog Over Orienteringer, August 2025

If you have a question about an orientation please contact horizonscanning@amgros.dk.

: {{ capitalizeFirst(item.pharmaceuticalSubstance) }}

{{ capitalizeFirst(orientering.pharmaceuticalSubstance) }} {{ capitalizeFirst(item.pharmaceuticalSubstance) }}
{{ orientering.productname }} {{ item.productname }}
{{ orientering.atC_code }} {{ item.atC_code }}
{{ orientering.dispensingForm }} {{ item.dispensingForm }}
{{ orientering.indication }} {{ item.indication }}
{{ orientering.formOfIndicationExtension }} {{ item.formOfIndicationExtension }}
{{ orientering.company }} {{ item.company }}
{{ orientering.expectedHospitalReservation }} Formodentlig sekundær sektor {{ item.expectedHospitalReservation }}
{{ orientering.emaMainPhase }} {{ item.emaMainPhase }}

{{getLink(link.linkId).order}}




Tidsperspektiv for markedsføringstilladelse i Danmark:
(Godkendes via processen for {{getTranslation(item.emA_procedure + "_plural")}}. Procedurenummer {{item.procedurenummer}}) (Godkendes via processen for {{getTranslation(item.emA_procedure + "_plural")}}, som {{getCommaSeparatedItemsAsString()}}. Procedurenummer {{item.procedurenummer}})

HS Tidslinje
Det betyder farverne: Hvid = dato er passeret, Gul = dato for aktuel status, Blå = estimeret dato

Studier Intervention Komparator Primær outcome Sekundær outcome Afsluttet
Land:
Fase:
N:
{{studie.studienr}}{{getLetter(studie.order)}}
 January 2026


  1. {{link.text}}


Ansvarlig:



Sortering

Søg


{{x.pharmaceuticalSubstance}} {{x.productname || 'NA'}} {{x.detailedProcedureProcessFlow}} {{x.atC_code}} {{x.indication}} {{x.publishedOn | date:'dd-MM-yyyy'}}

If you experience problems with our website, please let us know